Nu Skin Enterprises Inc
Gesloten
7.3 3.69
Overzicht
Wijziging aandelenprijs
24u
Min
7.02
Max
7.31
Inkomsten | -2.6M 14M |
|---|---|
Verkoop | 6.1M 370M |
K/W Sectorgemiddelde | 2.26 19.47 |
Dividendrendement | 3.34 |
Winstmarge | 3.913 |
Werknemers | 2,800 |
EBITDA | 3.9M 36M |
Dividendrendement Sectorgemiddelde | 3.34% 2.97% |
|---|---|
Volgende Winsten | 7 mei 2026 |
Volgende dividenddatum | 10 jun 2026 |
Volgende Ex Dividend datum | 29 mei 2026 |
Marktkapitalisatie | -130M 347M |
|---|---|
Vorige openingsprijs | 3.61 |
Vorige sluitingsprijs | 7.3 |
Technische score
By Trading Central
Vertrouwen
Bearish Evidence
Nu Skin Enterprises Inc Grafiek
Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.
Gerelateerd nieuws
Peer Vergelijking
Prijswijziging
Nu Skin Enterprises Inc Prognose
Financieel
Verkoop- en administratiekosten
Bedrijfskosten
Winst voor belastingen
Verkoop
Kosten van verkopen
Brutowinst op verkopen
Rente-uitgaven op schulden
EBITDA
Operationele winst
$
Over Nu Skin Enterprises Inc
Nu Skin Enterprises, Inc., together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products. The company also provides wellness products, such as LifePak nutritional supplements, ageLOC TR90 weight management system, and Beauty Focus Collagen+. In addition, it is involved in the research and product development of skin care products and nutritional supplements. The company sells its products under the Nu Skin, Pharmanex, and ageLOC brands through retail stores, website, digital platforms, and independent direct sellers and marketers, as well as a service center. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.
